MedPal AI (LSE:MPAL) has introduced Juno, a new agentic artificial intelligence health companion designed to proactively engage with patients and support ongoing healthcare management through the company’s digital ecosystem.
Unlike traditional AI tools that respond only when prompted, Juno continuously monitors patient information through MedPal’s Health OS platform and can initiate interactions through channels including WhatsApp and web-based interfaces. The launch positions the company within the growing market for AI agents capable of managing tasks and workflows on behalf of users.
New AI Architecture Powers Expanded Capabilities
The launch follows a significant upgrade to MedPal AI’s technology infrastructure.
The company has replaced its previous Google Vertex AI framework with a multi-layered architecture built around Anthropic’s latest Claude models and hosted on DigitalOcean infrastructure. The new system has been developed to support clinical response functions and more advanced patient engagement capabilities.
Juno has been trained using expertise from MedPal’s clinical team and is designed to assist users with healthcare guidance, symptom triage and access to medical services.
Integrated Pathway From Consultation to Treatment
The company said Juno forms part of a broader connected healthcare model that links AI-powered support with clinical and pharmacy services.
Through the platform, patients can receive guidance and triage support, connect with MedPal’s in-house general practitioners, arrange prescriptions and coordinate medication fulfilment and delivery. The system can also follow up with patients after treatment, creating what the company describes as a closed-loop care pathway.
Management believes the integration of AI, clinical services and pharmacy operations strengthens MedPal’s vertically integrated healthcare offering while improving patient access and convenience.
Building a Connected Digital Health Ecosystem
Juno operates through MedPal’s Health OS platform, which aggregates health information from more than 100 wearable devices and health applications into a single user profile.
The platform uses this data to provide personalised wellness recommendations while acting as a gateway to both NHS and private prescription services.
Alongside its digital health tools, MedPal operates an AI-powered pharmacy distribution centre through subsidiary MedPal Limited. The facility uses BD Rowa VMAX robotic dispensing technology to automate prescription fulfilment and support medication delivery across the UK.
Expanding User Reach
The company also continues to benefit from its partnership with Epassi UK, which provides temporary exclusive access to the MedPal app at no cost to more than 11 million employees across major organisations.
MedPal believes the combination of proactive AI assistance, clinical support and automated pharmacy fulfilment positions the business to capitalise on growing demand for integrated digital healthcare solutions.
More about MedPal AI
MedPal AI is a UK-based digital health and pharmacy technology company focused on connecting AI-powered wellness tools, healthcare services and automated medication fulfilment through its MedPal Health OS platform. The group combines patient data aggregation, clinical services and pharmacy operations to provide end-to-end healthcare support, serving both NHS and private prescription markets.
Leave a Reply